𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Gemtuzumab ozogamicin in combination with attenuated doses of standard induction chemotherapy can successfully induce complete remission without increasing toxicity in patients with acute myeloid leukemia aged 55 or older

✍ Scribed by Ki-Seong Eom; Hee-Je Kim; Woo-Sung Min; Seok Lee; Chang-Ki Min; Byung-Sik Cho; Sung-Yong Kim; Yoo-Jin Kim; Dong-Gun Lee; Su-Mi Choi; Seok-Goo Cho; Dong-Wook Kim; Jong-Wook Lee; Wan-Shik Shin; Chun-Choo Kim


Book ID
114794277
Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
191 KB
Volume
79
Category
Article
ISSN
0902-4441

No coin nor oath required. For personal study only.